Literature DB >> 26268891

Identification of a novel de novo GATA3 mutation in a patient with HDR syndrome.

Liu Chen1, Bing Chen1, Wuilin Leng1, Xiaotian Lui1, Qinan Wu1, Xinshou Ouyang2, Ziwen Liang3.   

Abstract

We describe the case of a 21-year-old male with hypocalcaemia, hyperphosphataemia, recurrent limb twitch, deafness, proteinuria, increased serum creatinine and urea nitrogen levels, and shrinkage of both kidneys. Brain computed tomography showed intracranial calcifications. The patient was diagnosed with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome. DNA sequence analysis of the GATA3 gene showed a novel de novo mutation, c. 529dupC (p. Arg177profs*126), in exon 2, resulting in a frameshift mutation with a premature stop codon after a new 126 amino acid sequence. We provide further evidence that HDR syndrome is caused by haploinsufficiency of GATA3.
© The Author(s) 2015.

Entities:  

Keywords:  GATA3; HDR syndrome; mutation analysis; phenotypic spectrum

Mesh:

Substances:

Year:  2015        PMID: 26268891     DOI: 10.1177/0300060515591065

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  3 in total

1.  Gata3 Silencing Is Involved in Neuronal Differentiation and Its Abnormal Expression Impedes Neural Activity in Adult Retinal Neurocytes.

Authors:  Pei Chen; Yihui Wu; Jiejie Zhuang; Xuan Liu; Qian Luo; Qiyun Wang; Zihua Jiang; Anqi He; Shuilian Chen; Xi Chen; Jin Qiu; Yan Li; Ying Yang; Keming Yu; Jing Zhuang
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

2.  Novel heterozygous GATA3 and SLC34A3 variants in a 6-year-old boy with Barakat syndrome and hypercalciuria.

Authors:  Sha Yu; Wen-Xia Chen; Wei Lu; Chao Chen; Yihua Ni; Bo Duan; Bin Wang; Huijun Wang; Zheng-Min Xu
Journal:  Mol Genet Genomic Med       Date:  2020-03-10       Impact factor: 2.183

3.  Hypoparathyroidism, Sensorineural deafness and renal disease (Barakat syndrome) caused by a reduced gene dosage in GATA3: a case report and review of literature.

Authors:  Anne D D Joseph; Nirmala D Sirisena; Thirunavukarasu Kumanan; Vathualan Sujanitha; Veronika Strelow; Raina Yamamoto; Stefan Wieczorek; Vajira H W Dissanayake
Journal:  BMC Endocr Disord       Date:  2019-10-28       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.